SCHEMBL26110100

SCHEMBL26110100

NC(=O)c1nc2ccccc2n(CC(O)C(O)C(O)CO)c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP1 P29466 3/20 0.47
▸ CASP7 P55210 3/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ MMP9 P14780 1/20 0.46
▸ MAOA P21397 1/20 0.46
▸ MAOB P27338 1/20 0.46
▸ ALDH1A1 P00352 4/20 0.44
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ MAPT P10636 3/20 0.44
▸ CYP2C19 P33261 3/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ HTT P42858 2/20 0.44
▸ OPRM1 P35372 2/20 0.41
▸ OPRD1 P41143 2/20 0.41
▸ OPRK1 P41145 2/20 0.41
▸ OGFRL1 Q5TC84 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYP1A2 P05177 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26110110 1.00 CASP1 (0.47) CASP1CASP7MAPK1MMP9MAOA
SCHEMBL30621225 0.81 KMT2A (0.58) CASP1CASP7MAPK1ALDH1A1MEN1
SCHEMBL22071670 0.81 KMT2A (0.58) CASP1CASP7MAPK1ALDH1A1MEN1
SCHEMBL22071682 0.81 KMT2A (0.58) CASP1CASP7MAPK1ALDH1A1MEN1
SCHEMBL5717810 0.78 ALDH1A1 (0.58) CASP1CASP7MAPK1ALDH1A1MEN1
SCHEMBL26111945 0.77 MEN1 (0.39) CASP1CASP7MAPK1ALDH1A1MEN1
SCHEMBL26111937 0.77 MEN1 (0.39) CASP1CASP7MAPK1ALDH1A1MEN1
SCHEMBL22830404 0.73 GSR (0.52) CASP1CASP7MAPK1MMP9MAOA
SCHEMBL23965851 0.71 MEN1 (0.72) CASP1CASP7MAPK1MMP9MAOA
SCHEMBL29457737 0.71 MEN1 (0.72) CASP1CASP7MAPK1MMP9MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023191379-A1 3,4-DIHYDROQUINOXALINE-2-CARBOXIMIDE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING CANCER DISEASE 재단법인 대구경북첨단의료산업진흥재단 2023-10-05 — — WO disclosed
Send feedback